Abstract
Immunological methods are widely applied in medical diagnostics for the detection and quantification of a plethora of analytes. Associated analytical challenges usually require these assays to be performed in a central laboratory. During the last several years, however, the clinical demand for rapid immunodiagnostics to be performed in the immediate proximity of the patient has been constantly increasing. Biosensors constitute one of the key technologies enabling the necessary, yet challenging transition of immunodiagnostic tests from the central laboratory to the point of care. This review is intended to provide insights into the current state of this transition process with a focus on the role of biosensor-based systems. To begin with, an overview on standard immunodiagnostic tests presently employed in the central laboratory and at the point of care is given. The review then moves on to demonstrate how biosensor technologies are resha** this landscape. Single analyte as well as multiplexed immunosensors applicable to point of care scenarios are presented. A section on the areas of clinical application then creates the bridge to day-to-day diagnostic practice. Finally, the depicted developments are critically weighed and future perspectives discussed in order to give the reader a firm idea on the forthcoming trends to be expected in this diagnostic field.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-019-01915-x/MediaObjects/216_2019_1915_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-019-01915-x/MediaObjects/216_2019_1915_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-019-01915-x/MediaObjects/216_2019_1915_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-019-01915-x/MediaObjects/216_2019_1915_Fig4_HTML.png)
Similar content being viewed by others
Abbreviations
- Ab:
-
Antibody
- AFP:
-
Alpha-fetoprotein
- AKI:
-
Acute kidney injury
- ALP:
-
Alkaline phosphatase
- BPE:
-
Bipolar electrode
- BNP:
-
B-type natriuretic peptides
- CA199:
-
Cancer antigen 19-9
- CBP:
-
Calcium-binding protein
- CDx:
-
Companion diagnostics
- CEA:
-
Carcinoembryonic antigen
- CK-MBmass :
-
Creatinine kinase MB
- CLIA:
-
Clinical Laboratory Improvement Amendments
- ECL:
-
Electrochemiluminescence
- FRET:
-
Förster resonance energy transfer
- GMR:
-
Giant magnetoresistance
- HRP:
-
Horseradish peroxidase
- IGFBP-7:
-
Insulin-like growth factor-binding protein 7
- ICT:
-
Immunochromatographic test
- IFN-γ:
-
Interferon-γ
- IL-n:
-
Interleukin n
- ISF:
-
Interstitial fluid
- IVD:
-
In vitro diagnostics
- KIM-1:
-
Kidney injury molecule-1
- LFA:
-
Lateral flow immunoassays
- LFD:
-
Lateral flow device
- LLOD:
-
Lower limits of detection
- MW:
-
Molecular weight
- NGAL:
-
Neutrophil gelatinase-associated lipocalin
- NWA:
-
Nanowell array
- PMMA:
-
Poly(methyl methacrylate)
- POCT:
-
Point-of-care testing
- PSA:
-
Prostate-specific antigen
- PTFE:
-
Polytetrafluoroethylene
- SAW:
-
Surface acoustic wave
- SPCE:
-
Screen-printed carbon electrode
- SPE:
-
Screen-printed electrode
- SPR:
-
Surface plasmon resonance
- SWNT:
-
Single-wall carbon nanotube
- TDM:
-
Therapeutic drug monitoring
- TNF:
-
Tumor necrosis factor
- TPA:
-
Tripropylamine
- TSH:
-
Thyroid-stimulating hormone
- TIMP-2:
-
Tissue inhibitor of metalloproteinases-2
References
von Lode P. Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. Clin Biochem. 2005;38(7):591–606. https://doi.org/10.1016/j.clinbiochem.2005.03.008.
Luppa PB, Sokoll LJ, Chan DW. Immunosensors - principles and applications to clinical chemistry. Clin Chim Acta. 2001;314(1–2):1–26.
Luppa PB, Junker R. Point-of-care testing. Principles and clinical applications, vol 1. 1 edn. Berlin: Springer. 2018. https://doi.org/10.1007/978-3-662-54497-6.
Luppa PB, Bietenbeck A, Beaudoin C, Giannetti A. Clinically relevant analytical techniques, organizational concepts for application and future perspectives of point-of-care testing. Biotechnol Adv. 2016;34(3):139–60. https://doi.org/10.1016/j.biotechadv.2016.01.003.
Vashist SK, Luppa PB, Yeo LY, Ozcan A, Luong JHT. Emerging technologies for next-generation point-of-care testing. Trends Biotechnol. 2015;33(11):692–705. https://doi.org/10.1016/j.tibtech.2015.09.001.
Vashist SK. Point-of-care diagnostics: recent advances and trends. Biosensors. 2017;7(4). https://doi.org/10.3390/bios7040062.
Bietenbeck A, Junker R, Luppa PB. Central laboratory service and point-of-care testing in Germany. From conflicting notions to complementary understandings. Point of Care. 2015;14(1):1–11. https://doi.org/10.1097/poc.0000000000000043.
Wang P, Kricka LJ. Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation. Clin Chem. 2018;64(10):1439–52. https://doi.org/10.1373/clinchem.2018.287052.
Sakamoto S, Omagari K, Kita Y, Mochizuki Y, Naito Y, Kawata S, et al. Magnetically promoted rapid immunoreactions using functionalized fluorescent magnetic beads: a proof of principle. Clin Chem. 2014;60(4):610–20. https://doi.org/10.1373/clinchem.2013.211433.
Felix FS, Angnes L. Electrochemical immunosensors - a powerful tool for analytical applications. Biosens Bioelectron. 2018;102:470–8. https://doi.org/10.1016/j.bios.2017.11.029.
Ko Ferrigno P. Non-antibody protein-based biosensors. Essays Biochem. 2016;60(1):19–25. https://doi.org/10.1042/EBC20150003.
Li Z, Chen G-Y. Current conjugation methods for immunosensors. Nanomaterials (Basel). 2018;8(5). https://doi.org/10.3390/nano8050278.
Mao SY. Biotinylation of antibodies. Methods Mol Biol. 2010;588:49–52. https://doi.org/10.1007/978-1-59745-324-0_7.
Omi K, Ando T, Sakyu T, Shirakawa T, Uchida Y, Oka A, et al. Noncompetitive immunoassay detection system for haptens on the basis of antimetatype antibodies. Clin Chem. 2015;61(4):627–35. https://doi.org/10.1373/clinchem.2014.232728.
Bradbury A, Plückthun A. Reproducibility: standardize antibodies used in research. Nature. 2015;518(7537):27–9. https://doi.org/10.1038/518027a.
Bradbury ARM, Trinklein ND, Thie H, Wilkinson IC, Tandon AK, Anderson S, et al. When monoclonal antibodies are not monospecific: hybridomas frequently express additional functional variable regions. MAbs. 2018;10(4):539–46. https://doi.org/10.1080/19420862.2018.1445456.
Knappik A, Ge L, Honegger A, Pack P, Fischer M, Wellnhofer G, et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol. 2000;296(1):57–86.
Frenzel A, Hust M, Schirrmann T. Expression of recombinant antibodies. Front Immunol. 2013;4. https://doi.org/10.3389/fimmu.2013.0021710.
Aydin S. A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides. 2015;72:4–15. https://doi.org/10.1016/j.peptides.2015.04.012.
Gao Y, Huang X, Zhu Y, Lv Z. A brief review of monoclonal antibody technology and its representative applications in immunoassays. J Immunoass Immunochem. 2018;39(4):351–64. https://doi.org/10.1080/15321819.2018.1515775.
Glahn-Martinez B, Benito-Pena E, Salis F, Descalzo AB, Orellana G, Moreno-Bondi MC. Sensitive rapid fluorescence polarization immunoassay for free mycophenolic acid determination in human serum and plasma. Anal Chem. 2018;90(8):5459–65. https://doi.org/10.1021/acs.analchem.8b00780.
Baibich MN, Broto JM, Fert A, Vandau FN, Petroff F, Eitenne P, et al. Giant magnetoresistance of (001)Fe/(001) Cr magnetic superlattices. Phys Rev Lett. 1988;61:2472–5.
Binasch G, Grunberg P, Saurenbach F, Zinn W. Enhanced magnetoresistance in layered magnetic-structures with antiferromagnetic interlayer exchange. Phys Rev B. 1989;39:4828–30.
Ismail AA. Identifying and reducing potentially wrong immunoassay results even when plausible and “not-unreasonable”. Adv Clin Chem. 2014;66:241–94.
Clerico A, Belloni L, Carrozza C, Correale M, Dittadi R, Dotti C, et al. A black swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods. Clin Chem Lab Med. 2018;56(3):397–402.
Thomas L. Labor und Diagnose. 8 edn. New York: TH-Books, Frankfurt/Main. 2012.
Klewitz T. Entwicklung eines quantitativen Lateral-Flow-Immunoassays zum Nachweis von Analyten in geringsten Konzentrationen. Inauguraldissertation. Hannover: Universität Hannover. 2005.
Inverness m, BioStar OIA GC (2006) An enhanced optical immunoassay for the rapid detection of Neisseria gonorrhoeae from female endocervical swabs and male urine specimens. Product insert. Inverness Medical Innovations, vol Rev 02. Waltham, MA, USA.
Miocevic O, Cole CR, Laughlin MJ, Buck RL, Slowey PD, Shirtcliff EA. Quantitative lateral flow assays for salivary biomarker assessment: a review. Front Public Health. 2017;5:133. https://doi.org/10.3389/fpubh.2017.00133.
Burbelo PD, Gunti S, Keller JM, Morse CG, Deeks SG, Lionakis MS, et al. Ultrarapid measurement of diagnostic antibodies by magnetic capture of immune complexes. Sci Rep. 2017;7(1):3818. https://doi.org/10.1038/s41598-017-03786-7.
Kozel TR, Burnham-Marusich AR. Point-of-care testing for infectious diseases: past, present, and future. J Clin Microbiol. 2017;55(8):2313–20. https://doi.org/10.1128/JCM.00476-17.
Luppa PB, Müller C, Schlichtiger A, Schlebusch H. Point-of-care testing (POCT): current techniques and future perspectives. Trends Anal Chem. 2011;30(6):887–98. https://doi.org/10.1016/j.trac.2011.01.019.
Justino CI, Duarte AC, Rocha-Santos TA. Immunosensors in clinical laboratory diagnostics. Adv Clin Chem. 2016;73:65–108. https://doi.org/10.1016/bs.acc.2015.10.004.
Kokkinos C, Economou A, Prodromidis MI. Electrochemical immunosensors: critical survey of different architectures and transduction strategies. Trends Anal Chem. 2016;79:88–105. https://doi.org/10.1016/j.trac.2015.11.020.
Cho IH, Lee J, Kim J, Kang MS, Paik JK, Ku S, et al. Current technologies of electrochemical immunosensors: perspective on signal amplification. Sensors (Basel). 2018;18(1). https://doi.org/10.3390/s18010207.
Contreras-Naranjo JE, Aguilar O. Suppressing non-specific binding of proteins onto electrode surfaces in the development of electrochemical immunosensors. Biosensors. 2019;9(1). https://doi.org/10.3390/bios9010015.
Damborsky P, Svitel J, Katrlik J. Optical biosensors. Essays Biochem. 2016;60(1):91–100. https://doi.org/10.1042/EBC20150010.
Wang Z, Zong S, Wu L, Zhu D, Cui Y. SERS-activated platforms for immunoassay: probes, encoding methods, and applications. Chem Rev. 2017;117(12):7910–63. https://doi.org/10.1021/acs.chemrev.7b00027.
Geissler D, Hildebrandt N. Recent developments in Förster resonance energy transfer (FRET) diagnostics using quantum dots. Anal Bioanal Chem. 2016;408(17):4475–83. https://doi.org/10.1007/s00216-016-9434-y.
Chen Y, **anyu Y, Wu J, Dong M, Zheng W, Sun J, et al. Double-enzymes-mediated bioluminescent sensor for quantitative and ultrasensitive point-of-care testing. Anal Chem. 2017;89(10):5422–7. https://doi.org/10.1021/acs.analchem.7b00239.
Wolfbeis OS. Fiber-optic chemical sensors and biosensors. Anal Chem. 2000;72(12):81R–9R.
Becker H, Gärtner C. Microfluidics-enabled diagnostic systems: markets, challenges, and examples. Methods Mol Biol. 2017;1547:3–21. https://doi.org/10.1007/978-1-4939-6734-6_1.
Nasseri B, Soleimani N, Rabiee N, Kalbasi A, Karimi M, Hamblin MR. Point-of-care microfluidic devices for pathogen detection. Biosens Bioelectron. 2018;117:112–28. https://doi.org/10.1016/j.bios.2018.05.050.
Dincer C, Bruch R, Kling A, Dittrich PS, Urban GA. Multiplexed point-of-care testing - xPOCT. Trends Biotechnol. 2017;35(8):728–42. https://doi.org/10.1016/j.tibtech.2017.03.013.
Munge BS, Stracensky T, Gamez K, DiBiase D, Rusling JF. Multiplex immunosensor arrays for electrochemical detection of cancer biomarker proteins. Electroanalysis. 2016;28(11):2644–58. https://doi.org/10.1002/elan.201600183.
Tang J, Tang D, Niessner R, Chen G, Knopp D. Magneto-controlled graphene immunosensing platform for simultaneous multiplexed electrochemical immunoassay using distinguishable signal tags. Anal Chem. 2011;83(13):5407–14. https://doi.org/10.1021/ac200969w.
Wan Y, Deng W, Su Y, Zhu X, Peng C, Hu H, et al. Carbon nanotube-based ultrasensitive multiplexing electrochemical immunosensor for cancer biomarkers. Biosens Bioelectron. 2011;30(1):93–9. https://doi.org/10.1016/j.bios.2011.08.033.
Feng X, Gan N, Zhou J, Li T, Cao Y, Hu F, et al. A novel dual-template molecularly imprinted electrochemiluminescence immunosensor array using Ru (bpy)32+−silica@poly-L-lysine-Au composite nanoparticles as labels for near-simultaneous detection of tumor markers. Electrochim Acta. 2014;139:127–36. https://doi.org/10.1016/j.electacta.2014.07.008.
Wu MS, Liu Z, Shi HW, Chen HY, Xu JJ. Visual electrochemiluminescence detection of cancer biomarkers on a closed bipolar electrode array chip. Anal Chem. 2015;87(1):530–7. https://doi.org/10.1021/ac502989f.
Sardesai NP, Barron JC, Rusling JF. Carbon nanotube microwell array for sensitive electrochemiluminescent detection of cancer biomarker proteins. Anal Chem. 2011;83(17):6698–703. https://doi.org/10.1021/ac201292q.
Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol. 2010;28(6):595–9. https://doi.org/10.1038/nbt.1641.
Wilson DH, Rissin DM, Kan CW, Fournier DR, Piech T, Campbell TG, et al. The Simoa HD-1 analyzer: a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing. J Lab Autom. 2016;21(4):533–47. https://doi.org/10.1177/2211068215589580.
Seo Y, Jeong S, Lee J, Choi HS, Kim J, Lee H. Innovations in biomedical nano-engineering: nanowell array biosensor. Nano Converg. 2018;5(1):9. https://doi.org/10.1186/s40580-018-0141-6.
Graham H, Chandler DJ, Dunbar SA. The genesis and evolution of bead-based multiplexing. Methods. 2019;158:2–11. https://doi.org/10.1016/j.ymeth.2019.01.007.
Agarwal R, Heinz T. Bedside hemoglobinometry in hemodialysis patients: lessons from point-of-care testing. ASAIO J. 2001;47(3):240–3.
Lehmann CA, Giacini JM. Point-of-care testing in the home and community environment: key ingredients for tomorrow’s community health. In: Price CP, St John A, Kricka LJ, editors. Point-of-care testing. 3rd ed. Washington: AACC Press; 2010.
Wurcel V, Perche O, Lesteven D, Williams DA, Schäfer B, Hopley C, et al. The value of companion diagnostics: overcoming access barriers to transform personalised health care into an affordable reality in Europe. Public Health Genomics. 2016;19(3):137–43.
Hafner G, Peetz D, Dati F. Patientennahe Bestimmung der Troponine zur diagnostik akuter koronarsyndrome. Near-patient testing of troponins for the diagnosis of acute coronary syndromes. J Lab Med. 2003;27(7–8):279–87. https://doi.org/10.1046/j.1439-0477.2003.03048.x.
Collinson P. Detecting cardiac events - state-of-the-art. Ann Clin Biochem. 2015;52(Pt 6):702–4. https://doi.org/10.1177/0004563215596761.
Peetz D, Hafner G, Lackner KJ. Patientennahe Bestimmung natriuretischer peptide. Near-patient testing of natriuretic peptides. J Lab Med. 2005;29(4):219–28. https://doi.org/10.1515/jlm.2005.030.
Banerjee R, Jaiswal A. Recent advances in nanoparticle-based lateral flow immunoassay as a point-of-care diagnostic tool for infectious agents and diseases. Analyst. 2018;143(9):1970–96. https://doi.org/10.1039/c8an00307f.
Stürenburg E, Junker R. Point-of-care testing in microbiology: the advantages and disadvantages of immunochromatographic test strips. Dtsch Arztebl Int. 2009;106:48–54.
Reinert RR. Streptokokkenschnelltests. Rapid streptococcal antigen detection tests. J Lab Med. 2007;31(6):280–93. https://doi.org/10.1515/jlm.2007.046.
Stenken JA, Poschenrieder AJ. Bioanalytical chemistry of cytokines - a review. Anal Chim Acta. 2015;853:95–115. https://doi.org/10.1016/j.aca.2014.10.009.
Pawlak M, Schick E, Bopp MA, Schneider MJ, Oroszlan P, Ehrat M. Zeptosens’ protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics. 2002;2(4):383–93. https://doi.org/10.1002/1615-9861(200204)2:4<383::AID-PROT383>3.0.CO;2-E.
Potuckova L, Franko F, Bambouskova M, Draber P. Rapid and sensitive detection of cytokines using functionalized gold nanoparticle-based immuno-PCR, comparison with immuno-PCR and ELISA. J Immunol Methods. 2011;371(1–2):38–47. https://doi.org/10.1016/j.jim.2011.06.012.
Duking P, Achtzehn S, Holmberg HC, Sperlich B. Integrated framework of load monitoring by a combination of smartphone applications, wearables and point-of-care testing provides feedback that allows individual responsive adjustments to activities of daily living. Sensors (Basel). 2018;18(5). https://doi.org/10.3390/s18051632.
Kiang TKL, Ranamukhaarachchi SA, Ensom MHH. Revolutionizing therapeutic drug monitoring with the use of interstitial fluid and microneedles technology. Pharmaceutics. 2017;9(4). https://doi.org/10.3390/pharmaceutics9040043.
Singh V, Krishnan S. Electrochemical and surface plasmon insulin assays on clinical samples. Analyst. 2018;143(7):1544–55. https://doi.org/10.1039/c7an01872j.
Wood F, Brookes-Howell L, Hood K, Cooper L, Verheij T, Goossens H, et al. A multi-country qualitative study of clinicians’ and patients’ views on point of care tests for lower respiratory tract infection. Fam Pract. 2011;28(6):661–9. https://doi.org/10.1093/fampra/cmr031.
Dunn SG, Visnich MR. Home-based point-of-care testing. In: Kost GJ, editor. Princinples and practice of point-of-care testing. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 376–90.
Siebenhofer A, Jeitler K, Horvath K, Habacher W, Schmidt L, Semlitsch T. Self-management of oral anticoagulation. Dtsch Arztebl Int. 2014;111(6):83–91. https://doi.org/10.3238/arztebl.2014.0083.
Robinson JE, Wakelin M, Ellis JE. Increased pregnancy rate with use of the Clearblue easy fertility monitor. Fertil Steril. 2007;87(2):329–34. https://doi.org/10.1016/j.fertnstert.2006.05.054.
Friedewald S, Finke E-J, Dobler G. Patientennahe Diagnostik in Krisensituationen. J Lab Med. 2006;30:211–8.
Kost GJ, Ferguson WJ, Hoe J, Truong AT, Banpavichit A, Kongpila S. The Ebola spatial care path: accelerating point-of-care diagnosis, decision making, and community resilience in outbreaks. Am J Disaster Med. 2015;10(2):121–43. https://doi.org/10.5055/ajdm.2015.0196.
Price CP, St. John A. Innovation in healthcare. The challenge for laboratory medicine. Clin Chim Acta. 2014;427:71–8.
Deutsches Institut für Normung. DIN 58964:2015-09 - quality assurance of POCT results. Assessment criteria for comparison measurement and implementation. Berlin: Beuth Verlag. 2015.
Zhang WR, Parikh CR (2019) Biomarkers of acute and chronic kidney disease. Annu Rev Physiol 81:309-333. doi: https://doi.org/10.1146/annurev-physiol-020518-114605. (Feb 10):309-333.
Funding
This work was supported in part by the European Commission (NANODEM, #318372) and the Bundesministerium für Bildung und Forschung (Q-Flow, #13N13867 and KAREL, #13GW0154D).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Published in the topical collection New Developments in Biosensors with guest editors Francesco Baldini and Maria Minunni.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Poschenrieder, A., Thaler, M., Junker, R. et al. Recent advances in immunodiagnostics based on biosensor technologies—from central laboratory to the point of care. Anal Bioanal Chem 411, 7607–7621 (2019). https://doi.org/10.1007/s00216-019-01915-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-019-01915-x